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Background: In-vitro and animal studies using EDC cross-linked membranes have shown great resistance to enzymatic
digestion as well as low cytotoxicity, and indicated its potential expediency as a barrier membrane for guided
bone regeneration (GBR). The purpose of this study was to evaluate the efficacy, biocompatibility and degradation
kinetics of a novel 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC)-cross-linked type I collagen membrane
for regeneration of rabbit calvarial defects. EDC cross-linked type I collagen membrane and macroporous
biphasic calcium phosphate (MBCP) consisting of 60 % hydroxyapatite and 40 % β-tricalcium phosphate were
used in this study. Four circular defects (ø = 8 mm) were created in each calvarium of 12 male white rabbits. The
experimental groups randomly allocated to the defects were as follows – (1) sham control, (2) EDC-cross-linked collagen
membrane (EDC membrane), (3) bone graft (BG), and (4) bone graft with collagen membrane (B-EDC membrane).
Specimens were harvested at 2 weeks (n = 6) and 8 weeks (n = 6) postoperatively for observational histology and
histometrical analysis.
Result: The histologic observation showed close adaptation of the EDC membrane to the defect perimeters
along with vascularization of the membrane at 2 weeks. Direct apposition of new bone on to the collagen matrix
could be observed displaying adequate tissue integration. Collapsing of the central portion of the membrane
could be seen in the EDC membrane group, and both BG and B-EDC membrane groups showed greater total
augmented area and new bone area than the EDC membrane group. The membrane was largely unresorbed at
2 weeks; and at 8 weeks the overall shape of the membrane was still maintained suggesting sustained barrier
function at 8 weeks.
Conclusion: Within the limits of this study, it may be concluded that EDC-cross-linked collagen membrane is a
safe biomaterial with adequate tissue integration and resorption kinetics to support bone regeneration when
used in conjunction with bone filler.
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Guided Bone Regeneration (GBR) involves the surgical
placement of barrier membranes in order to create and
maintain a secluded space to promote osseous prolifera-
tion [1–4]. The ideal barrier membrane must be biocom-
patible, cell-occlusive, integrated by the host tissues,
clinically manageable and able to uphold space [1, 5].
Although expanded polytetrafluoroethylene (e-PTFE)
had been accepted as the gold standard material, suscepti-
bility to exposure with subsequent progression of infection
as well as the need for second surgical intervention had
led to development of resorbable membranes. A resorba-
ble membrane that would allow transmembraneous angio-
genesis, but effectively exclude undesired cells from the
clot would have the advantage of not requiring surgical
removal.
Collagen membranes have advantages related to bio-
logical properties of collagen itself such as minimal in-
flammation and cytotoxicity, ability to facilitate cellular
growth [6, 7], hemostatic ability, allowing early wound
stabilization, semipermeability allowing nutrient passage,
and chemotactic ability to attract fibroblasts [8]. Further-
more, collagen membranes are mechanically malleable,
adaptable, and easy to manipulate during clinical proce-
dures. Successful GBR using native collagen membranes is
well-documented in the literature [2–4, 9–13]. However,
the disadvantage of native collagen is inherent in the dur-
ation of barrier function which cannot be strictly con-
trolled where loss of structural integrity and solubilization
via phagocytosis may precede the completion of healing
[14]. Similarly, early removal of e-PTFE membranes have
been reported to resulted in reduced bone formation and
incomplete bone fill [15, 16]. Hence in order to reinforce
collagen membrane, various methods have been intro-
duced to cross-link collagen. [12, 17, 18]. Several in vivo
studies have demonstrated that cross-linked collagen
membranes display prolonged membrane integrity com-
pared with the non-cross-linked membranes [11, 12].
Although cross-linking of collagen is a commonly used
procedure, its impact on physicochemical properties of
the membrane is unknown. Previous studies have reported
increase in perforation incidence at cross-linked collagen
membrane sites compared to non-crosslinked membrane
sites [12, 14]. Increasing degrees of cross-linking have in-
dicated compromise in biocompatibility of the membrane.
Rothamel et al. have reported the tendency of cross-linked
collagen membrane to split from adjacent connective tis-
sues as well as lack of vascularization in the early healing
phase and foreign body reactions in three differently
cross-linked collagen membranes in rat [19]. Crosslinking
agents such as ultraviolet radiation, glutaraldehyde,
diphenyl-phosphorylation-azide have been reported to in-
duced inflammatory reactions and failure to integrate with
host tissues. Nevertheless, certain cross-linked collagenmembrane using polysaccharide has shown a degree of
success for bone regeneration. Furthermore, Zubery et al.
have reported osseous integration of ribose cross-linked
collagen membrane in the canine jaw and humans [4, 20].
1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC)
has widely been used in cross-linking of collagen in bio-
medical materials. However, to the best of our knowledge,
publications in EDC-cross-linked collagen membrane for
GBR procedure are scarce. In-vitro and animal studies using
EDC-cross-linked porous membranes have shown great re-
sistance to enzymatic digestion as well as low cytotoxicity,
and have indicated its potential expediency as a scaffold in
tissue engineering [6, 21, 22]. Recently, a new EDC-cross-
linked collagen membrane has been developed for use in
GBR and guided tissue regeneration (GTR). This mem-
brane apparently has resilience to enzymatic degradation,
biocompatibility, cell-occlusiveness, space maintenance and
ideal modulus of elasticity for surgical manipulation. In a
preceding study, Lee et al. investigated this collagen mem-
brane [23], and found minimal surface resorption had oc-
curred after 4 weeks of healing, and new bone had ossified
beneath the membrane suggesting high bio-compatibility
between the membrane and osteblasts [3, 23].
The aim of this study was to investigate the EDC-cross-
linked type-I collagen membrane for the regeneration of
rabbit calvarial defects at 2 and 8 weeks. Histological sam-
ples were examined to evaluate the biocompatibility, effi-
cacy and degradation kinetics of the EDC-cross-linked
type-I collagen membrane. Synthetic bone graft particles
consisting of 60 % hydroxyapatite and 40 % β-tricalcium
phosphate were used in combination with the barrier
membrane in this study, as addition of bone grafts or
space provision agents has been regarded essential for suc-
cessful GBR [24, 25].
Materials and methods
Collagen barrier membrane
A commercially available collagen membrane cross-
linked using 1-ethyl-3-(3-dimethylaminopropyl) carbo-
diimide (EDC) was used (Rapigide, Dalim Tissen, Korea)
(Fig. 1a). The collagen membranes were immersed in a
5 mM EDC solution for 24 h at 4 °C for cross-linking,
followed by thorough washing and re-lyophilization.
Bone graft
Macro–micro porous biphasic calcium phosphate gran-
ules (MBCP™) consisting of 60 % hydroxyapatite and 40 %
β-tricalcium phosphate was used (Biomatlante, France)
(Fig. 1b). The granules are 1-2 mm in size with 70 %
porosity.
Animals
Twelve male New Zealand White rabbits weighing 2.8-
3.2 kg and aged 16–20 weeks were used in this study.
Fig. 1 Collagen membrane and biphasic calcium phosphate. (a) A novel EDC crosslinked collagen membrane (Dalim Tissen©) was applied over
the defects. (b) Biphasic calcium phosphate particles (MBCP) consisting of 60 % hydroxyapatite and 40 % β-tricalcium phosphate were used
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preparation followed routines approved by the Institu-
tional Animal Care and Use Committee, Yonsei Medical
Center, Seoul, Korea.
Study design
Four defects of 8 mm in diameter were created in each
animal. The depth of the defects comprised full thickness
of the calvarial bone, with slight variation in thickness
according to individual specimen and location within
the calvarium. Therefore the defects were randomly
assigned to the following 4 groups: empty control,
EDC-cross-linked collagen membrane (EDC membrane
group), bone graft (BG group), and bone graft with
EDC-cross-linked collagen membrane (B-EDC membrane
group). The animals were euthanized at either 2 or 8 weeks
postoperative (Fig. 2).
Surgical protocol
General anaesthesia was induced in all animals using
intramuscular injections of zoletil (15 mg/kg) and rompun
(5 mg/kg). The head of the rabbit was shaved and disin-
fected using Povidone iodine prior to local anaesthetic
injections at the surgical site using 2.2 ml lidocaine
hydrochloride 2 % with adrenaline 1:80,000. An incision
was made along the midline of the cranium from theFig. 2 The surgical procedure. (a) Four circular defects (ø = 8 mm) were cre
were randomly assigned to the defects. (b) Random assignment of the def
(CM), bone graft with collagen membrane (B-CM) and bone graft only (BG
histologic and histometric analysisfrontal bone to the occipital bone in order to expose
the entire calvarium. A full-thickness flap was elevated.
Under copious saline irrigation, four standardized
round defects, each 8 mm in diameter, were created
using a trephine bur. The resected bone windows were
removed carefully to avoid injury to the underlying
brain tissue. The four experimental groups described
above were randomly applied to the defects created.
For the groups containing bone graft, the amount of
graft particles were standardized to completely fill each
defect by application of gentle pressure using a surgical
instrument. For the groups containing the barrier mem-
brane (i.e. EDC membrane and B-EDC membrane
groups), the membrane was cut to the size of 10 × 10 mm
to cover the entire perimeter of each defect. The flaps
were repositioned and sutured with a resorbable suture
material. The animals were sacrificed at either 2 weeks
(n = 6) or 8 weeks (n = 6) postoperative. The skin flaps
were then reflected and the entire calvarium was harvested
from each animal.
Histologic processing
Block sections of the surgical sites were fixed in 10 %
formalin for 10 days. The fixed specimens were decalci-
fied in 5 % formic acid for 14 days and then embedded
in paraffin. Serial 5 μm thick sections were cut throughated in each calvarium of 12 male white rabbits, and four groups
ects clockwise from top left - control group, collagen membrane only
). Specimens were harvested at 2 and 8 weeks postoperatively for
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sections located at the middle of the defects were selected,
and stained with hematoxylin-eosin and Masson Tri-
chrome for histologic observation and histomorphometric
analysis.
Clinical observations
Animals were carefully observed for inflammation, allergic
reactions, and other complications around the surgical site
throughout the 2 and 8 week healing periods. The spec-
imens were also inspected at the time of sacrifice once
the calvarial bone including the experimental sites were
harvested from the animal.
Histological observations
The specimens were examined under a microscope (DM
LB, Leica Microsystems, Wetzlar, Germany) equipped
with a camera (DC300F, Leica Microsystems, Wetzlar,
Germany) by one blinded examiner. Images of the slides
were acquired and saved as digital files.
Histomorphometric analysis
After the conventional microscopic examination,
computer-assisted histometric measurements in the cal-
varial defect were performed using an automated image
analysis system (Image-Pro Plus; Media Cybernetics, Silver
Spring, MD). The following parameters were measured
from each histologic section of the defect areas.
 Remaining membrane area (RM) – Area of the
barrier membrane remaining within the defect.
 New bone area (NB) – Area of newly formed bone
within the defect.
 Total augmented area (TA) – Total area contained
within the CM or periosteum superiorly, lateral
boundaries of the defect and the dura matter
inferiorly. This consists of the sum of the area of
new bone, residual particles, connective tissue,
adipose tissue and blood vessels within the defect.
 Residual particle (RP) – Area of the remaining bone
graft particles within the defect.
Statistical analysis
The statistical analysis was performed using a commercially
available software program (SPSS 18.0, SPSS, Chicago, IL).
Histomorphometric records from the calvarial defect
samples were used to calculate the mean and standard
deviation (SD) values of the four groups (i.e. control, BG,
CM, B-CM). Kruskal Wallis test and Mann-Whitney U
test (nonparametric analysis of variance) was used to
analyze the difference between the groups at each time
periods, and also to compare the same experimental
group between the two healing periods. Statistical sig-
nificance was considered when P < 0.05.Results
Clinical observations
Healing was uneventful, and no signs of adverse inflam-
matory reaction or complications were observed at the
surgical sites prior to sacrifice. At visual inspection of
the surgical sites during harvesting, primary closure of
the flaps was confirmed and no exposure of the mem-
branes through the overlying periosteum was noticed.
All experimental sites remained intact. The defect spaces
appeared encapsulated by periosteum and dura mater,
preventing discharge of any defect constituents such as
the bone graft particles.
Histologic observations
Control group
At 2 weeks, woven bone structures were observed occur-
ring from the defect margins (Fig. 3a). The defects were
mainly occupied by the overlying soft tissues that had
collapsed into the space. The periosteum appeared to
contain many blood vessels. Infiltration of inflammatory
cells, mainly macrophages, as part of the normal healing
sequence could be observed in even distribution through-
out the experimental site.
At 8 weeks, formation of bony islands were seen on
central areas of the defect (Fig. 4a), which can be con-
strued to be the products of osteogenic activity from the
surrounding periosteum and dura mater [26]. Almost
full closure along the diameter of the defect could be
seen on certain histological sections; however the height
of the restored bone was far below the level of the native
bone. The remaining defect spaces were filled by the
overlying soft tissues and dense fibrous tissues. A clear
decrease in the number of inflammatory cells could be
observed compared to the histologic view at 2 weeks
(Fig. 4a).
EDC membrane group
At 2 weeks, the collagen membrane appeared structur-
ally intact and displayed close marginal adaptation to the
native bone at the perimeter of the defects. Formation of
blood vessels could be seen around the collagen mem-
brane in close proximity to the membrane (Fig. 3b). Col-
lapsing of the collagen membrane at the central region
in addition to the elevation of the underlying dura mater
resulted in the subsequent elimination of majority of the
defect space. Wedge-shaped woven bone structures pro-
truded from the perimeter of the defects. The new bone
growths towards the central direction were confined by
the intruding barrier membrane. Appearance of inflam-
matory cells, mainly macrophages, as part of the wound
healing sequence could be seen at the experimental site.
The macrophages were seen to be gathered in concen-
trated clusters distributed in and around the implanted
materials.
Fig. 3 Histologic view after 2 weeks of healing, showing – (a) control group; defect is mainly occupied by the overlying soft tissues that had
collapsed into the space. (b) Collagen membrane group; membrane appeared structurally intact and displayed close marginal adaptation to the
native bone at the perimeter of the defects. (c) Bone graft group; defect space is well-maintained compared to the EDC group. (d) Bone graft
with collagen membrane group; defect space is well-maintained by the barrier membrane and the supporting bone graft particles. X40 magnification
view, Trichrome staining
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the original thickness and shape seen at 2 weeks (Fig. 4b).
Mature new bone with osteocytes was formed mainly at
the perimeters and at the central areas as bony islands
(Figure 5a). New bone was integrated with the collagenous
network of the membrane and gradually occupied the space
in which the membrane existed previously (Figs. 4b and 6).
At high magnification, secretion of new bone matrix by os-
teoblasts could be observed within the collagen membrane,
and the secreted new bone was fully integrated with theFig. 4 Histologic view after 8 weeks of healing showing – (a) control grou
fibrous tissues. (b) Collagen membrane group; the collagen membrane sho
place. New bone was integrated with the collagenous network of the mem
existed previously. (c) Bone graft group; Mature new bone formation could
surrounded by fibrous tissue and the regenerated bone was slightly below
membrane group; new bone surrounded the bone graft particles, which w
New bone formation extended from the native bone at the defect perime
bone. X40 magnification view, Trichrome stainingmembrane. Furthermore, formation of blood vessels could
be seen within the membrane space (Fig. 6b). More sparse
distribution of inflammatory cells could be observed with
clear reduction in numbers compared to 2 weeks.
BG group
At 2 weeks, defect space was well-maintained compared
to the EDC membrane group (Fig. 3c and b). The bone
graft particles formed an irregular margin against the
overlying soft tissues with encapsulation by the fibrousp; defect spaces were filled by the overlying soft tissues and dense
wed clear reduction in structural integrity as resorption had taken
brane and gradually occupied the space in which the membrane
be observed. The superficial layer of bone graft particles were
the original height of native bone. (d) Bone graft with collagen
ere interconnected to form complete closure of the defect space.
ter into the covering membrane that was closely adapted to the native
Fig. 5 Higher magnification view of the defect sites at 8 weeks, Trichrome staining. (a) Histologic view of CM group showing islets of new bone
(NB) integrated within the CM at the middle of the defect. Depression of the collapsed CM and elevation of the dura mater (DM) resulting in
subsequent elimination of defect space. Nevertheless, new bone (NB) formation occurred integrated within the CM. (b) Histologic view of
collagen membrane (CM) in the B-CM group showing new bone (NB) integrated to the network of collagen membrane. CM is closely adapted to
the native bone (OB) at the defect perimeter. Effective space provision is provided by the bone graft (BG) particles. Vascularization of the mem-
brane can be seen throughout the membrane (arrows)
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could be observed, clustered around each bone graft par-
ticle as well as from the native bone at the perimeters. In
comparison to the B-EDC membrane group, fewer graft
particles appeared to be present in the BG group. Inflam-
matory cells appeared in similar appearance to the EDC
membrane group distributed in concentrated clusters
around the implanted materials.
At 8 weeks, lamellar bone structures with osteocytes
could be observed; however, fibrous tissues still occu-
pied areas inside the defect (Fig. 4c). The superficial
layer of bone graft particles were surrounded by fibrous
tissue and the new bone was restored slightly below the
original height of native bone. Little resorption of theFig. 6 Bone formation around EDC membrane at 8 weeks. (a) EDC membr
membrane space. X40 magnification, Hematoxylin & eosin staining.(b) Forma
New bone is appeared to be maturing into lamellar structures as seen by t
Newly formed bone is in contact with the membrane structures (CM), whic
membrane. Formation of transmembraneous blood vessels (BV) can also b
Hematoxylin & eosin stainingbone graft particles appeared to have taken place at
8 weeks compared to 2 weeks. (Figs. 4c and 3c).
B-EDC group
At 2 weeks, early new bone appeared mainly around par-
ticles at the base of the defect. Blood vessels formation
was noticed within the collagen membrane (Fig. 3d).
The defect space was well-maintained by the barrier
membrane and the supporting bone graft particles. The
augmented areas were often greater than the original
bone area as packing of the bone graft particles during
the surgical procedure expanded the defect space by
exerting pressure onto the underlying dura mater. In-
flammatory cells were again found in similar appearanceane group at 8 weeks showing mature new bone formation within the
tion of new bone matrix (NB) by the osteoblasts (arrows) can be seen.
he appearance of osteocytes and the resulting Haversian system.
h suggests good biocompatibility and tissue integration of the EDC
e seen occurring within the membrane space. X400 magnification,
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trated clusters around implanted materials.
At 8 weeks, new bone surrounded the bone graft parti-
cles, which were interconnected to form complete clos-
ure of the defect space (Fig. 4d). New bone formation
extended from the native bone at the defect perimeter
into the covering membrane that was closely adapted to
the native bone (Figure 5b). Clear reduction in the area
of the membrane could be seen; however, little resorp-
tion of the graft particles had taken place compared to
2 weeks. More sparse distribution of inflammatory cells
could be observed with clear reduction in numbers com-
pared to 2 weeks.
Histomorphometric analysis
The results from the histomorphometric analysis are
listed on Table 1.
2 weeks
At 2 weeks, there was no significant difference between
the control group and the EDC group in terms of TA
and NB. BG group and B-EDC membrane group both
showed greater TA compared to the control group with
statistical significance (P = 0.006, P = 0.006, respectively).
In regards to the NB, although BG and B-EDC mem-
brane groups showed greater mean NB than the control,
this was not statistically significant (P = 0.055, P = 0.126,
respectively). Both BG and B-EDC groups showed
greater TA and NB compared to the EDC membrane
group with statistical significance (TA: P = 0.004, 0.004,
NB: P = 0.008, 0.037, respectively).
8 weeks
At 8 weeks, there was no significant difference between
the control group and the EDC membrane group in
terms of TA and NB. BG group and B-EDC membraneTable 1 Histomorphometric analysis at 2 and 8 weeks
postoperative
Group Total
augmented
area
Residual
particle
New bone Remaining
membrane
2 weeks Control 4.21 ± 1.52 - 0.95 ± 0.81b -
EDC 3.49 ± 1.07 - 0.95 ± 0.31b 5.51 ± 0.73b
BG 10.04 ± 2.03a 2.39 ± 1.00 1.93 ± 0.61b -
B-EDC 11.49 ± 2.82ab 3.17 ± 1.05 1.98 ± 0.70b 5.58 ± 0.97b
8 weeks Control 5.21 ± 1.40 - 2.76 ± 0.92b -
EDC 4.23 ± 1.00 - 2.11 ± 0.64b 1.98 ± 1.89b
BG 12.54 ± 1.64a 2.70 ± 0.73 4.76 ± 1.61ab -
B-EDC 14.59 ± 3.13ab 2.84 ± 0.66 5.10 ± 1.68ab 1.47 ± 1.65b
Statistically significant difference from the control group
aStatistically significant difference from the membrane group
bStatistically significant difference between the same experimental group
between 2 and 8 weeksgroup both showed greater TA compared to the control
group with statistical significance (P = 0.006, P = 0.006,
respectively). In regards to mean NB, both BG and B-
EDC membrane groups were greater than the control
group with only the B-EDC membrane group showing
statistically significant difference (P = 0.018). Both BG
and B-EDC groups showed greater TA and NB than
the EDC membrane group with statistically significant
difference (TA: P = 0.004, 0.004, NB: P = 0.010, 0.004,
respectively).
Between 2 & 8 weeks
In all 4 groups, statistically significant difference was
shown in regards to NB between 2 and 8 weeks (control:
P = 0.016, EDC membrane: P = 0.010, BG: P = 0.010, B-
EDC membrane: P = 0.004).
The RM had decreased from 2 to 8 weeks, displaying
68 % mean resorption over 6 weeks. This difference was
statistically significant in both EDC membrane groups
and B-EDC membrane groups between 2 and 8 weeks
(P = 0.010, P = 0.004, respectively).
The RP of both BG and B-EDC membrane groups be-
tween 2 and 8 weeks showed no difference statistically.
This result concurs with the histological observation in
which no visible reduction in RP could be detected.
Discussion
1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC)
has widely been used in cross-linking of collagen in bio-
medical materials. In-vitro and animal studies using
EDC cross-linked membranes have shown great resist-
ance to enzymatic digestion as well as low cytotoxicity,
and indicated its potential expediency as a barrier mem-
brane for guided bone regeneration (GBR). The EDC
membrane in this study showed prolonged duration of
function shown by the maintenance of the overall outward
shape at 8 weeks. In addition, despite recent reports of
compromised biocompatibility in cross-linked collagen
membranes, the EDC membrane displayed remarkable
tissue integration with minimal immune reactions as
observed clinically and histologically. The observations
of the current study has demonstrated that increased
bio-durability of collagen membranes can be achieved
with favorable adaptation to the surrounding tissues.
Tissue integration and biocompatibility are important
criteria to fulfill for resorbable barrier membranes in order
to minimize immunological response and membrane ex-
posure. This is more relevant for the cross-linked variety
as degradation product of the cross-linking agent have
been shown to cause foreign body reactions. For instance,
increasing degrees of cross-linking have been associated
with reduced biocompatibility through in vitro cultures
[27]. Cross-linking of collagen was shown to be associated
with decreased tissue integration and vascularization.
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were linked with increased cytotoxicity [28]. Similarly, in a
human study, a cross-linked collagen membrane with pro-
longed resorption time demonstrated significantly more
adverse events and less bone regeneration compared to
the native collagen membrane [14]. On the other hand,
certain cross-linked collagen membranes using polysac-
charides has been shown to be favorable for GBR proce-
dures despite the findings of spontaneous early exposures
[4, 17, 20]. Although exposure of collagen membranes to
the oral environment has been reported to cause disinte-
gration of the membrane [11], Sela et al. have demon-
strated in this case that cross-linked CMs were more
resistant to proteolysis than the native CM [29]. Unlike
the previously studied cross-linked CMs, the current
membrane did not produce soft tissue dehiscence in any
of the surgical sites, and wound healing occurred without
complication. Histologically, the membrane appeared to
be well-integrated to the native bone with formation of
vascular network throughout the defect sites; transmem-
braneous angiogenesis has been shown to play a crucial
role in early new bone formation in the native CM [30, 31].
The aim of this study was to investigate the EDC-
cross-linked collagen membrane (EDC-CM) for GBR
procedure in the rabbit calvarial defect model. The cal-
varial defect has spontaneous healing capacity due to its
contained morphology bounded by tissues encompassing
osteogenic capacity such as the native bone, periosteum
and dura mater. In the present study, 8 mm-diameter
defects were used, which is less than the critical-size dem-
onstrated by Sohn et al. [26]. Consequently, all of the
groups including the control showed statistically signifi-
cant increase in NB at 8 weeks compared to 2 weeks.
However, the current experimental model is ideal for com-
parison of multiple experimental groups, and inclusion of
a sham control eliminates the element of spontaneous
bone formation during inter-group analysis.
According to the histomorphometric analysis, there was
no difference between the control and EDC membrane
groups in terms of TA and NB at both 2 and 8 weeks.
However, with the addition of bone graft particles in the
BG and B-EDC membrane groups, significantly greater
TA and NB were produced. Notably, this result shows that
in the current experimental model, the amount of new
bone formation is directly related to the space maintained
by the implanted materials. The histologic observations
showed that the defect spaces were not well-maintained
by the collagen membranes as seen by the collapsing of
the membranes at the central portions. Although the
membrane appeared dimensionally stable at initial place-
ment during surgery, histologic evidence suggests that
mechanical strength is lost upon contact with surrounding
soft tissues, which is a typical drawback of the collagen
membranes [32]. Adequate space maintenance is providedonly when defect morphology is favorable and if the bony
defect cannot support itself, the membrane is prone to
collapse [33, 34]. Therefore, the results of the current
study demonstrate that the same principle is applied when
performing GBR with EDC-CM as the native CM in that
provision of support by bone grafting is essential for
space-making.
In this study, synthetic bone filler consisting of macro-
porous biphasic calcium phosphate particles were used.
Bone fillers are effective for providing support for resorba-
ble membranes while preventing the risk of autogenous
bone harvest [35]. Biphasic calcium phosphate produced
minimal immune response at 2 weeks. Vascularization oc-
curred around the particles but displayed minimal amount
of resorption at 8 weeks. New bone proliferated directly
onto the bone substitute particles demonstrating both
osteoconductivity and osteoinductivity of the biomaterial.
In the present study, comparable amounts of new bone
were obtained between the BG group and B-EDC mem-
brane group. This is due to the contained morphology of
the calvarial defect in the current study. Still, less residual
particles were present in the BG group sites compared to
the B-EDC membrane group, and the outline of the newly
formed bone at the surface appeared more orderly in the
B-EDC group. Also, fibrous encapsulation of the grafted
particles at the superficial aspect was visible in the BG
group; whereas in the B-EDC membrane group, new bone
formation occurred along the membrane surface and inte-
grated with the collagen matrix. This observation suggests
that the use of barrier membrane enhanced new bone for-
mation by preventing the infiltration of soft tissues and
stabilizing the graft particles during surgical manipulation.
In the clinical situation where augmentation of alveolar
bone volume is often attempted in various defect morph-
ologies, such barrier membrane would be crucial to
maximize bone formation and to prevent scattering of the
graft particles.
EDC has been found to modify side-groups on proteins
to make them reactive with other side-groups and to me-
diate the ester bond formation between the hydroxyl and
carboxyl groups. In contrast to conventional chemical
agents such as glutaraldehyde or polypeptides, carbodii-
mides do not remain as a part of that linkage but simply
change to water-soluble urea derivatives that have very
low cytotoxicity. At the same time, EDC cross-linked
membrane has been characterized to possess great resist-
ance to enzymatic digestion and be toxicologically accept-
able [6, 21, 22]. In the present study, no clinically
abnormal reactions were noticed during the observation
period of 8 weeks. Histologically, aggregation of macro-
phages was seen on 2-week specimens around grafted ma-
terials including the membrane and the bone substitute
particles. The concentration of immune cells decreased at
8 weeks suggesting that the appearance of macrophages
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close adaptation of the EDC membrane to the defect
perimeters were observed along with evidence of
vascularization at 2 weeks. Direct apposition of new
bone on to the collagen matrix could be observed,
which shows satisfactory tissue integration and biocom-
patibility. This is a similar finding to an observation in
another study that demonstrated tissue integration of a
ribose-cross-linked collagen membrane, in which ossifica-
tion developed beneath the collagen membrane and new
bone showed adherence to the membrane [11, 14, 20].
Space maintenance duration has been reported to be
another important factor strongly influencing the out-
come of GBR [36]. Previous studies using e-PTFE mem-
brane has shown that early removal of the membrane
may result in reduced bone formation. For instance, a
study in dogs has shown that bone regeneration was not
completed at 4 months, and has demonstrated a definite
gradient from the marginal portion toward the middle
zone of the defect, where the formation of primary spon-
giosa was still going on, particularly in the roof of the
defect [36]. Therefore, several clinicians have advocated
that membranes used for GBR should last longer, 6–9
months, than guided tissue regeneration (GTR). Cross-
linked collagen membranes have been shown to be more
resistant to in vivo degradation than non-cross-linked
membranes [19, 29]. In addition, a previous report has
demonstrated a negative correlation between the degree
of cross-linking and resorption rate [19]. Lee et al. have
shown uniform absorption and maintenance of the out-
ward shape at 4 weeks using the EDC-CM [23]. The ap-
pearance of the membrane in the current study illustrates
that the overall shape of the membrane was still main-
tained after 8 weeks despite of the overall area resorption
of approximately 68 %. This indicates that prolonged
membrane function may be provided by the EDC-CM in
comparison to the native collagen membrane, which has
been shown to disintegrate as early as 4 weeks.
Recent reports have claimed a certain shift in para-
digm in regards to necessity of collagen cross-linking
through series of studies that demonstrate compromised
biocompatibility in cross-linked collagen membranes
[19, 27, 28, 30, 31]. Studies have indicated that treatment
outcomes are not significantly influenced by membrane
resorption time but mainly dependent upon the pres-
ence or absence of membrane exposure and/or space
collapse [11, 32]. A commercially available native type I
and III porcine collagen membrane has been reported to
exhibit ideal tissue integration and vascularization result-
ing in a nearly complete biodegradation 4 weeks following
implantation. Nonetheless, a biocompatible cross-linked
collagen membrane with a prolonged barrier function
would produce optimal outcome for GBR; as shown histo-
logically in this study, better quantity and quality of bonewas formed at the superficial layer of the defect when
EDC-CM was used along with bone filler. The present
study agrees with the statement that cross-linking of colla-
gen membrane increases the resistance to biodegradation,
meanwhile the capacity to tissue integrate has not been
compromised using the EDC-CM.
Conclusion
Within the limits of this study, it may be concluded that
EDC-cross-linked collagen membrane is a safe biomaterial
with adequate tissue integration and resorption kinetics to
support bone regeneration when used in conjunction with
bone fillers. Further study should be conducted for direct
comparison between native collagen membrane and EDC-
CM. Also more challenging defect morphology for alveo-
lar bone augmentation than the current model should be
employed with longer healing period to properly test the
effectiveness of EDC-CM for GBR.
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